The main clinical indications included acute lymphoblastic leukaemia, Parkinson's disease, haemophilia, defects of the bladder, knee cartilage lesions, adenosine deaminase deficiency, melanoma, stroke, multiple sclerosis and retinal disease. The gene discussed is ADA; the disease is hyperinsulinemic hypoglycemia, familial, 4.